Truist Financial’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.15M | Sell |
5,927
-5,787
| -49% | -$1.2M | ﹤0.01% | 1680 |
|
|
2026
Q1 | $2.63M | Buy |
11,714
+573
| +5% | +$143K | ﹤0.01% | 1163 |
|
|
2025
Q4 | $2.68M | Buy |
11,141
+715
| +7% | +$183K | ﹤0.01% | 1133 |
|
|
2025
Q3 | $2.85M | Sell |
10,426
-234
| -2% | -$63.9K | ﹤0.01% | 1161 |
|
|
2025
Q2 | $2.75M | Buy |
10,660
+183
| +2% | +$43.7K | ﹤0.01% | 1133 |
|
|
2025
Q1 | $2.35M | Buy |
10,477
+1,730
| +20% | +$404K | ﹤0.01% | 1144 |
|
|
2024
Q4 | $2M | Buy |
8,747
+3,418
| +64% | +$823K | ﹤0.01% | 1231 |
|
|
2024
Q3 | $1.3M | Sell |
5,329
-339
| -6% | -$75.8K | ﹤0.01% | 1407 |
|
|
2024
Q2 | $1.08M | Sell |
5,668
-519
| -8% | -$105K | ﹤0.01% | 1569 |
|
|
2024
Q1 | $1.23M | Sell |
6,187
-3,752
| -38% | -$688K | ﹤0.01% | 1515 |
|
|
2023
Q4 | $1.71M | Sell |
9,939
-971
| -9% | -$149K | ﹤0.01% | 1335 |
|
|
2023
Q3 | $1.61M | Sell |
10,910
-6,745
| -38% | -$1.22M | ﹤0.01% | 1345 |
|
|
2023
Q2 | $3.86M | Sell |
17,655
-2,033
| -10% | -$453K | 0.01% | 944 |
|
|
2023
Q1 | $4.31M | Sell |
19,688
-7,667
| -28% | -$1.66M | 0.01% | 883 |
|
|
2022
Q4 | $5.69M | Sell |
27,355
-1,453
| -5% | -$319K | 0.01% | 774 |
|
|
2022
Q3 | $6.29M | Sell |
28,808
-4,023
| -12% | -$916K | 0.01% | 703 |
|
|
2022
Q2 | $6.88M | Sell |
32,831
-3,236
| -9% | -$689K | 0.01% | 699 |
|
|
2022
Q1 | $8.75M | Buy |
36,067
+4,846
| +16% | +$1.17M | 0.01% | 685 |
|
|
2021
Q4 | $8.13M | Sell |
31,221
-1,627
| -5% | -$422K | 0.01% | 722 |
|
|
2021
Q3 | $8.66M | Sell |
32,848
-3,169
| -9% | -$867K | 0.01% | 685 |
|
|
2021
Q2 | $8.88M | Sell |
36,017
-1,209
| -3% | -$254K | 0.01% | 674 |
|
|
2021
Q1 | $7.22M | Sell |
37,226
-30,869
| -45% | -$6.19M | 0.01% | 711 |
|
|
2020
Q4 | $14.5M | Buy |
68,095
+720
| +1% | +$144K | 0.03% | 497 |
|
|
2020
Q3 | $11.6M | Buy |
67,375
+4,000
| +6% | +$739K | 0.03% | 513 |
|
|
2020
Q2 | $12.2M | Sell |
63,375
-2,311
| -4% | -$378K | 0.03% | 481 |
|
|
2020
Q1 | $9.67M | Sell |
65,686
-908
| -1% | -$145K | 0.03% | 492 |
|
|
2019
Q4 | $10.3M | Buy |
66,594
+29,343
| +79% | +$4.23M | 0.02% | 569 |
|
|
2019
Q3 | $5.03M | Sell |
37,251
-669
| -2% | -$87.7K | 0.09% | 226 |
|
|
2019
Q2 | $4.63M | Sell |
37,920
-2,091
| -5% | -$232K | 0.08% | 234 |
|
|
2019
Q1 | $4.16M | Sell |
40,011
-405
| -1% | -$41.8K | 0.07% | 248 |
|
|
2018
Q4 | $4.6M | Buy |
40,416
+5
| +0% | +$536 | 0.09% | 217 |
|
|
2018
Q3 | $4.66M | Sell |
40,411
-2,138
| -5% | -$234K | 0.08% | 246 |
|
|
2018
Q2 | $4.41M | Sell |
42,549
-2,427
| -5% | -$246K | 0.08% | 249 |
|
|
2018
Q1 | $4.43M | Sell |
44,976
-3,646
| -7% | -$345K | 0.08% | 253 |
|
|
2017
Q4 | $4.12M | Sell |
48,622
-3,689
| -7% | -$305K | 0.08% | 268 |
|
|
2017
Q3 | $4.03M | Buy |
52,311
+2,792
| +6% | +$214K | 0.08% | 270 |
|
|
2017
Q2 | $3.86M | Buy |
49,519
+20,667
| +72% | +$1.48M | 0.08% | 282 |
|
|
2017
Q1 | $2.08M | Buy |
28,852
+3,383
| +13% | +$234K | 0.04% | 359 |
|
|
2016
Q4 | $1.58M | Sell |
25,469
-2,405
| -9% | -$147K | 0.03% | 394 |
|
|
2016
Q3 | $1.81M | Buy |
27,874
+934
| +3% | +$62.2K | 0.04% | 380 |
|
|
2016
Q2 | $1.7M | Buy |
+26,940
| New | +$1.59M | 0.04% | 390 |
|
Other funds holding RMD
TIA
WF
VF
AT
SAM
Truist Financial's RMD Position: Q2 2026 in Review
Truist Financial reduced its ResMed (RMD) stake by 49% in Q2 2026, selling an estimated $1.2M and leaving 5,927 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1680.
Truist Financial first reported a position in RMD in Q2 2016 and has held it in 41 quarters since. The position peaked at $14.5M in Q4 2020. 360 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Truist Financial held 5,927 shares of ResMed worth $1.15M as of Q2 2026.
- Truist Financial sold 5,787 ResMed shares in Q2 2026, an estimated $1.2M.
- ResMed made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #1680 holding.
- Truist Financial first reported a position in ResMed in Q2 2016 and has held it in 41 quarters since.
- Truist Financial's ResMed position peaked at $14.5M in Q4 2020.
- 360 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.